0001654954-24-001967.txt : 20240220
0001654954-24-001967.hdr.sgml : 20240220
20240220161116
ACCESSION NUMBER: 0001654954-24-001967
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240216
FILED AS OF DATE: 20240220
DATE AS OF CHANGE: 20240220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: lee ting-chuan
CENTRAL INDEX KEY: 0001859311
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41461
FILM NUMBER: 24653387
MAIL ADDRESS:
STREET 1: 8880 RIO SAN DIEGO DRIVE
STREET 2: SUITE 800
CITY: SAN DIEGO
STATE: CA
ZIP: 92108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ainos, Inc.
CENTRAL INDEX KEY: 0001014763
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 751974352
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: AINOS, INC.
STREET 2: 8880 RIO SAN DIEGO DRIVE SUITE 800
CITY: SAN DIEGO
STATE: CA
ZIP: 92108
BUSINESS PHONE: 858-869-2986
MAIL ADDRESS:
STREET 1: AINOS, INC.
STREET 2: 8880 RIO SAN DIEGO DRIVE SUITE 800
CITY: SAN DIEGO
STATE: CA
ZIP: 92108
FORMER COMPANY:
FORMER CONFORMED NAME: AMARILLO BIOSCIENCES INC
DATE OF NAME CHANGE: 19960516
4
1
section16.xml
PRIMARY DOCUMENT
X0508
4
2024-02-16
0001014763
Ainos, Inc.
AIMD
0001859311
lee ting-chuan
8880RIOSANDIEGODRIVE, SUITE800
SANDIEGO
CA
92108
true
false
CommonStock
2024-02-16
4
A
false
14400
0.8693
A
80831
D
RSU
2024-02-16
4
C
false
14400
D
CommonStock
14400
101200
D
Reference is made to (i) 480,000 RSUs that were granted on August 15, 2023, adjusted to 96,000 shares giving effect to the 1 for 5 reverse share split on December 14, 2023, pursuant to the Company's 2023 Stock Incentive Plan, with vesting occurringin increments of 15% on 2/15/24, 15% on 8/15/24,30% on 8/15/25, and 40% on 8/15/26 subject to normal and customary termination events; and (ii) 70,000 RSUs granted under the 2021 Stock Incentive Plan, as amended by the 2023 Stock Incentive Plan, adjusted to 14,000 shares giving effect to the 1 for 5 reverse share split on December 14, 2023, with vesting occurring in increments of 2,100 shares on 5/14/23 and 11/14/23, respectively, 4,200shares on 11/14/24 and 5,600 shares on 11/14/25, subject to normal and customary termination events.
/s/ Chun-Hsien Tsai per POA for Lee, Ting-Chuan
2024-02-20